Denali Advisors’s Utah Medical Products UTMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-120
| Closed | -$10K | – | 372 |
|
|
2021
Q1 | $10K | Hold |
120
| – | – | ﹤0.01% | 312 |
|
|
2020
Q4 | $10K | Sell |
120
-220
| -65% | -$18.3K | ﹤0.01% | 334 |
|
|
2020
Q3 | $27K | Sell |
340
-440
| -56% | -$34.9K | 0.01% | 319 |
|
|
2020
Q2 | $69K | Hold |
780
| – | – | 0.01% | 312 |
|
|
2020
Q1 | $73K | Sell |
780
-363
| -32% | -$34K | 0.02% | 270 |
|
|
2019
Q4 | $123K | Buy |
1,143
+1,097
| +2,385% | +$118K | 0.02% | 244 |
|
|
2019
Q3 | $4K | Sell |
46
-5,348
| -99% | -$465K | ﹤0.01% | 244 |
|
|
2019
Q2 | $516K | Buy |
5,394
+3,754
| +229% | +$359K | 0.08% | 144 |
|
|
2019
Q1 | $145K | Buy |
1,640
+1,620
| +8,100% | +$143K | 0.02% | 159 |
|
|
2018
Q4 | $2K | Hold |
20
| – | – | ﹤0.01% | 219 |
|
|
2018
Q3 | $2K | Buy |
+20
| New | +$2K | ﹤0.01% | 233 |
|
|
2018
Q1 | – | Sell |
-64
| Closed | -$5K | – | 297 |
|
|
2017
Q4 | $5K | Hold |
64
| – | – | ﹤0.01% | 157 |
|
|
2017
Q3 | $5K | Buy |
64
+31
| +94% | +$2.42K | ﹤0.01% | 146 |
|
|
2017
Q2 | $2K | Hold |
33
| – | – | ﹤0.01% | 233 |
|
|
2017
Q1 | $2K | Buy |
+33
| New | +$2K | ﹤0.01% | 232 |
|
|
2016
Q4 | – | Sell |
-39
| Closed | -$2K | – | 313 |
|
|
2016
Q3 | $2K | Hold |
39
| – | – | ﹤0.01% | 235 |
|
|
2016
Q2 | $2K | Hold |
39
| – | – | ﹤0.01% | 228 |
|
|
2016
Q1 | $2K | Hold |
39
| – | – | ﹤0.01% | 221 |
|
|
2015
Q4 | $2K | Buy |
+39
| New | +$2K | ﹤0.01% | 221 |
|